 |
|
|
|
|
|
|
| Health Care |
Summary of General Statutes Enacted at the 2007 Session of the Georgia General Assembly of Georgia - 8/07
Advocacy & Government Relations
August 15, 2007
Robert J. Lystad
Joel C. Williams, Jr.
A memorandum outlining select general statues enacted by the Georgia General Assembly during the 2007 legislative session.
|
|
HB 2007 Local Government - 8/8/07
Advocacy & Government Relations
August 8, 2007
Robert J. Lystad
HB 2007 Local Government
|
|
Latest Development: Spitzer's Press Release
September 16, 2005
Here is link to Spitzer's press release on the suit. http://www.oag.state.ny.us/press/2005/sep/sep15b_05.html
|
|
Hurricane Response: Government Suspends Certain Healthcare Laws - 9/12/05
Health Care Client Alert
September 12, 2005
Sandra K. Herron
In the wake of what many are calling the greatest disaster in United States history, both the Federal and the Louisiana State governments have suspended the application of certain healthcare laws to the extent necessary, in the words of the Secretary of Health and Human Services, "to ensure that sufficient health care items and services are available to meet the needs of individuals enrolled in Medicare, Medicaid and SCHIP programs, and to ensure that health care providers that furnish such items and services in good faith, but are unable to comply with one or more of these requirements as a result of the effects of Hurricane Katrina, may be reimbursed for such items and services and exempted from sanctions for such noncompliance, absent any determination."
|
|
Patient Care Ombudsman - 06/13/05
Health Care
June 13, 2005
Wendy L. Hagenau
Over the last five to ten years, the number of healthcare businesses filing bankruptcy petitions has greatly increased. The bankruptcy courts found themselves grappling not simply with business issues, but also with issues of patient care. Judges founds themselves sometimes ill-equipped to evaluate whether a business proposal or business strategy would in fact have adverse effects on patient care. As a result, the bankruptcy amendments have added a new section to address the needs of patients when the healthcare business is in bankruptcy.
|
|
CMS Issues Final MMA Section 1011 Guidance - 06/10/05
Health Care
June 10, 2005
On May 9, almost 10 months after publishing a proposed implementation notice, the Centers for Medicare and Medicaid Services (CMS) released the final implementation notice for Section 1011 of the Medicare Prescription Drug Improvement and Modernization Act of 2003, which authorizes $250 million each year in federal reimbursement from FYs 2005 through 2008 directly to hospitals, physicians, and ambulance services for the costs associated with providing emergency services to undocumented and other specified immigrants.
|
|
Busy Year for Guilty Pleas - 12/23/04
Advocacy & Government Relations
December 23, 2004
In 2004, ongoing investigations by the Criminal Enforcement section of the Antitrust Division of the United States Department of Justice resulted in high profile guilty pleas and large fines. In March of 2004, Crompton Corporation, a US manufacturer of rubber chemicals, plead guilty to conspiring with other rubber chemical producers to suppress and eliminate competition in the sale of rubber chemicals and agreed to pay a $50,000,000 fine. Joseph B. Eisenberg and James J. Conway. former executives of Crompton, subsequently also plead guilty.
|
|
Department of Health and Human Services Task Force Releases Report on Prescription Drug Importation - 12/23/04
December 23, 2004
Cynthia E. Berry
In this edition of the Advocacy & Government Relations Client Alert we discuss the final report (released on December 21) of the Department of Health and Human Services Task Force on Drug Importation. Reiterating that access to safe and affordable prescription drugs is an important policy goal, the Task Force concluded that drug importation would be costly to implement, provide little overall savings and, if not restricted to commercial importation from Canada, could be dangerous to consumers. The Task Force advised that all aspects of achieving safety, quality and cost-effectiveness must be comprehensively examined before imported drugs can be considered safe.
|
|
|
|
|
|
|
|
